title: Bioengineering in the Millennium, National Institute of Health Symposium, Bioengineering: Building the Future of Biology and Medicine.
abstract: This symposium identified the major challenges in biomedical research that will benefit from bioengineering applications. Attention was focused on the important role that bioengineers will play in future advances in biomedical research. There was considerable discussion about how to integrate bioengineering with biological research in meeting the challenges of the twenty-first century. Symposium presenters showcased the accomplishments of NIH-funded bioengineering researches and increased the visibility of bioengineering to NIH leaders, staff and members of the intramural and extramural research community. Recommendations were also made for future NIH-funded research projects. Attention was also placed on how basic bioengineering research can lead to commercialization of new health care technology and therefore maintain the Nation's leadership in this important area. New products, from biotechnology and novel devices for diagnosis and treatment, are marketed through interactions between universities, medical centers, small start-up firms, and larger, more established companies. In the United States the gross revenue of the bioengineering private sector industry involved in the manufacture of health care products already exceeds $40 billion. More than 750 persons attended this bioengineering symposium. Over 110 scientific posters and exhibits relating to biology and medicine were presented. They provided a forum for showcasing NIH-funded bioengineering projects and fostered future collaboration among academic investigators, industry and members of the small business community. The role of bioengineering in the 21st century has already been highlighted by the author as far as research, education and space age technologies are concerned. The contributions of Pugwash bioengineer, Maciej Natecz, a member of the Polish Academy of Sciences, was recognized by the Conference Planning Committee. He was honoured for his work in nuclear disarmament.
authors.forename: H S
authors.initials: HS
authors.lastname: Ranu
mesh_terms: D001672:Biocompatible Materials; D001695:Biology / Q000639:trends; D001698:Biomedical Engineering / Q000295:instrumentation / Q000379:methods / Q000639:trends*; D005544:Forecasting; D006801:Humans; D008511:Medicine; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D001672:Biocompatible Materials